According to FutureWise analysis, the leadless pacemakers market in 2024 was valued at US$703 million and is expected to reach US$1,635 million by 2033, growing at a CAGR of over 13%. The market's growth is driven by several factors, including the increasing prevalence of cardiac arrhythmias and a growing preference for minimally invasive procedures. Leadless pacemakers are gaining popularity due to their benefits over traditional systems, which include a lower risk of infection and shorter recovery periods. Additionally, continuous technological advancements and positive clinical outcomes are contributing to the global uptake of these innovative healthcare solutions.
Pacemakers send small electrical pulses to the heart muscles to maintain a stable heart rate or stimulate the lower chambers. A catheter, a thin long tube, is used to implant leadless pacemakers. A catheter is inserted into the femoral vein through a very small incision in patients’ groin. This area is numbed with a local anesthetic. The doctor uses an X-ray machine to guide the catheter to patient’s heart. After inserting the catheter, doctor will place the pacemaker in the right ventricle. It is tested to ensure that the device has been properly installed and programmed. The catheter is removed and pressure is applied to the incision site in order to close it. Pacemaker technology has advanced rapidly, including rate and output, to allow non-invasive connection with devices and better battery technology to increase the pulse generator's life duration by a year.
Every year, more than one million cardiac pacemakers are implanted throughout the world with about 200,000 of those procedures taking place in the US alone. These numbers are predicted to rise as a result of the ageing population and rising pace indicators. Cardiac pacemaker technology has advanced rapidly since the first pacemaker was implanted in the 1950s. The implantation and administration of transvenous cardiac pacemakers have undergone a revolution and transformation due to advances in battery life, pacemaker lead quality, algorithmic programming, and rate responsiveness (TV-PPM). The Nanostim Leadless Cardiac Pacemaker and the Medtronic Micra Transcatheter Pacing System are the two leadless pacing systems that are currently available. Both of these pacing systems use a catheter delivery system to be inserted into the femoral vein, but they differ in terms of size, fixation to the heart, and responsiveness.
FutureWise Market Research has published a report that provides an insightful analysis of leadless pacemakers’ market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the leadless pacemakers’ market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.